Timely Psychiatry
At Timely Psychiatry, we understand that living with depression—especially when it doesn’t respond to traditional treatments—can feel overwhelming. That’s why we’re proud to offer Spravato® (esketamine) nasal spray, an FDA-approved treatment specifically designed for adults suffering from treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal thoughts or behaviors.
Spravato® is a prescription nasal spray derived from ketamine, a medication that has shown rapid-acting antidepressant effects. Unlike traditional oral antidepressants that can take weeks to work, Spravato® may begin relieving symptoms within hours or days. When used in conjunction with an oral antidepressant, it offers new hope for those who haven’t found relief through other therapies.
Spravato® may be appropriate if you:
Have tried two or more antidepressants without success
Experience persistent symptoms of major depressive disorder
Are struggling with suicidal ideation or severe depressive episodes
Our psychiatric team will evaluate your unique situation to determine if Spravato® is right for you.
Spravato® is administered in-office at Timely Psychiatry under the supervision of our trained medical staff. Here’s what the treatment process looks like:
A comprehensive psychiatric assessment to determine eligibility.
Spravato® is typically administered twice a week for the first 4 weeks, then reduced to once weekly or biweekly depending on your response.
Each session includes a 2-hour observation period to ensure safety and comfort.
We closely monitor your progress and adjust treatment as needed.
If you or a loved one is struggling with depression that hasn’t responded to traditional treatment, Spravato® may offer new hope.